Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ehab Youssef"'
Publikováno v:
Egyptian Journal of Remote Sensing and Space Sciences, Vol 26, Iss 3, Pp 758-767 (2023)
Desertification leads to a decline in land production, resulting from biophysical interaction and human factors with temporal and spatial changes. This paper aims to evaluate the desertification sensitivity using Mediterranean Desertification and Lan
Externí odkaz:
https://doaj.org/article/a663337e237b4a759c13a2582ffb09c6
Autor:
Adel Shalaby, Hossam Khedr, Ehab Youssef, Neven Rostom, Hoda Nour-Eldin, Rania Mansour, Engy Hassan
Publikováno v:
Applied Geomatics. 15:15-28
Publikováno v:
Propellants, Explosives, Pyrotechnics. 46:995-1005
Publikováno v:
Cross-Sectional Imaging of the Abdomen and Pelvis ISBN: 9781493918836
Various pathologies can involve the liver. In this chapter, we start by illustrating the gross anatomy of the liver. Then, we briefly tabulate various focal hepatic lesions with a special emphasis placed on the imaging features and differential diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62689e7bfae809612bb8638306392a05
https://doi.org/10.1007/978-1-4939-1884-3_2
https://doi.org/10.1007/978-1-4939-1884-3_2
Autor:
Milton D. Gross, Domenico Rubello, Lorraine M. Fig, Alice Ferretti, Ehab Youssef, Ka Kit Wong
Publikováno v:
Endocrine reviews. 35(5)
Nuclear medicine imaging of endocrine disorders takes advantage of unique cellular properties of endocrine organs and tissues that can be depicted by targeted radiopharmaceuticals. Detailed functional maps of biodistributions of radiopharmaceutical u
Autor:
Mark S. Kaminski, Peter L. Roberson, Ehab Youssef, Lauren B. Smith, Jincheng Shen, Matthew J. Schipper, Denise Regan, Scott J. Wilderman, Jure Murgic, Yuni K. Dewaraja, Anca M. Avram, Hatice Savas
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 55(7)
The study aimed at identifying patient-specific dosimetric and nondosimetric factors predicting outcome of non-Hodgkin lymphoma patients after (131)I-tositumomab radioimmunotherapy for potential use in treatment planning.Tumor-absorbed dose measures